People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| INCOG BioPharma Services, Inc. | — | Pharma | Series C | $86.6M | $392.7M | 2024 |
Karen Blair at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Karen Blair on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Martin Van Trieste | 1 | 2 |
| Tedd Green | 1 | 1 |
| Doug Dayoff | 1 | 1 |
| Madhu Balachandran | 1 | 1 |
| Cory Lewis | 1 | 1 |
| Fabrizio Bonanni | 1 | 1 |
| Keith Skerrett | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.